The Latest Research

Filter by

showing 141 of 366

June 14, 2016

FDA approves monthly injectable medication daclizumab for relapsing forms of MS

June 8, 2016

Landmark MS Scientific Research Foundation funded study demonstrates that “rebooting” the immune system stops new disease and leads to recovery in people with aggressive multiple sclerosis

June 1, 2016

Researchers mine MS Scientific Research Foundation-funded biobank to discover a genetic mutation associated with an aggressive form of primary progressive MS

May 16, 2016

MS Society-funded research team develops and tests a new compound to promote myelin repair in mice

May 12, 2016

MS Society-funded team devises a new technique to study the movement of myelin-forming cells

May 3, 2016

MS Society-funded study shows that variations in vein anatomy of the neck are not limited to people living with MS

April 15, 2016

Two studies by MS Society-funded researcher shine the spotlight on comorbidity in multiple sclerosis

April 12, 2016

Pilot study takes a first step towards understanding how bacteria in the gut influence childhood MS

April 8, 2016

Study examines interactions between physical and emotional wellbeing in those with multiple sclerosis

March 8, 2016

MS Society-funded study explores ‘nanoparticles’ as a potential therapeutic strategy in mice with an MS-like disease

February 22, 2016

MS Society-funded doctoral student demonstrates the adaptive potential of a child’s brain in pediatric-onset MS

February 19, 2016

Breaking News: OCREVUS™ (ocrelizumab) is the first drug approved by the FDA for primary progressive MS

February 12, 2016

MS Society funds two new studies poised to bring laboratory discoveries one step closer to becoming treatments for progressive MS

February 9, 2016

MS Society-funded study shows that nicotine reduces the invasion of harmful immune cells into the brain in mice with an MS-like disease

January 18, 2016

Over $2.4 Million Committed to Support Seven Operating Grants to Explore the Relationship of CCSVI to Multiple Sclerosis

Interested in the national Quebec e-newsletter? Join our waitlist.

In Quebec, e-newsletters are created at the chapter level. Quebec residents can contact their local chapter and request to be added to their specific e-newsletter subscriber list.
Click here to view our Quebec chapters

About Multiple Sclerosis (MS)

Managing Multiple Sclerosis

Multiple Sclerosis Support

Leading MS Research

Join our efforts against MS

About MS Canada

About Multiple Sclerosis (MS)

Managing Multiple Sclerosis

Menu Find Support

Multiple Sclerosis Support

Leading MS Research

Join our efforts against MS

About MS Canada

The Latest Research

FDA approves monthly injectable medication daclizumab for relapsing forms of MS

Landmark MS Scientific Research Foundation funded study demonstrates that “rebooting” the immune system stops new disease and leads to recovery in people with aggressive multiple sclerosis

Researchers mine MS Scientific Research Foundation-funded biobank to discover a genetic mutation associated with an aggressive form of primary progressive MS

MS Society-funded research team develops and tests a new compound to promote myelin repair in mice

MS Society-funded team devises a new technique to study the movement of myelin-forming cells

MS Society-funded study shows that variations in vein anatomy of the neck are not limited to people living with MS

Two studies by MS Society-funded researcher shine the spotlight on comorbidity in multiple sclerosis

Pilot study takes a first step towards understanding how bacteria in the gut influence childhood MS

Study examines interactions between physical and emotional wellbeing in those with multiple sclerosis

MS Society-funded study explores ‘nanoparticles’ as a potential therapeutic strategy in mice with an MS-like disease

MS Society-funded doctoral student demonstrates the adaptive potential of a child’s brain in pediatric-onset MS

Breaking News: OCREVUS™ (ocrelizumab) is the first drug approved by the FDA for primary progressive MS

MS Society funds two new studies poised to bring laboratory discoveries one step closer to becoming treatments for progressive MS

MS Society-funded study shows that nicotine reduces the invasion of harmful immune cells into the brain in mice with an MS-like disease

Scientists test the feasibility of using Smartphones to study and monitor MS

Acne medication may delay progress of multiple sclerosis

MS Society of Canada commits $1 million for CCSVI clinical trial

MS Society partners in CCSVI clinical trial

MS Society welcomes new national monitoring system

Over $2.4 Million Committed to Support Seven Operating Grants to Explore the Relationship of CCSVI to Multiple Sclerosis

About Multiple Sclerosis (MS)

Managing Multiple Sclerosis

Multiple Sclerosis Support

Leading MS Research

Join our efforts against MS

About MS Canada

About Multiple Sclerosis (MS)

Managing Multiple Sclerosis

Multiple Sclerosis Support

Leading MS Research

Join our efforts against MS

About MS Canada

The Latest Research

FDA approves monthly injectable medication daclizumab for relapsing forms of MS

Landmark MS Scientific Research Foundation funded study demonstrates that “rebooting” the immune system stops new disease and leads to recovery in people with aggressive multiple sclerosis

Researchers mine MS Scientific Research Foundation-funded biobank to discover a genetic mutation associated with an aggressive form of primary progressive MS

MS Society-funded research team develops and tests a new compound to promote myelin repair in mice

MS Society-funded team devises a new technique to study the movement of myelin-forming cells

MS Society-funded study shows that variations in vein anatomy of the neck are not limited to people living with MS

Two studies by MS Society-funded researcher shine the spotlight on comorbidity in multiple sclerosis

Pilot study takes a first step towards understanding how bacteria in the gut influence childhood MS

Study examines interactions between physical and emotional wellbeing in those with multiple sclerosis

MS Society-funded study explores ‘nanoparticles’ as a potential therapeutic strategy in mice with an MS-like disease

MS Society-funded doctoral student demonstrates the adaptive potential of a child’s brain in pediatric-onset MS

Breaking News: OCREVUS™ (ocrelizumab) is the first drug approved by the FDA for primary progressive MS

MS Society funds two new studies poised to bring laboratory discoveries one step closer to becoming treatments for progressive MS

MS Society-funded study shows that nicotine reduces the invasion of harmful immune cells into the brain in mice with an MS-like disease

Scientists test the feasibility of using Smartphones to study and monitor MS

Acne medication may delay progress of multiple sclerosis

MS Society of Canada commits $1 million for CCSVI clinical trial

MS Society partners in CCSVI clinical trial

MS Society welcomes new national monitoring system

Over $2.4 Million Committed to Support Seven Operating Grants to Explore the Relationship of CCSVI to Multiple Sclerosis

Sign up for our e-newsletter